Castleview Partners’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-219
Closed -$18.7K 191
2024
Q4
$18.7K Buy
219
+1
+0.5% +$100 0.01% 477
2024
Q3
$20.6K Buy
218
+1
+0.5% +$89 0.01% 443
2024
Q2
$20.7K Buy
217
+1
+0.5% +$119 0.01% 435
2024
Q1
$28.5K Sell
216
-9
-4% -$1.11K 0.02% 423
2023
Q4
$32.6K Buy
225
+215
+2,150% +$29.5K 0.02% 370
2023
Q3
$1.7K Buy
+10
New +$1.99K ﹤0.01% 568
2022
Q4
Sell
-218
Closed -$58K 642
2022
Q3
$58K Buy
218
+63
+41% +$16K 0.06% 231
2022
Q2
$17.6K Buy
+155
New +$34.6K 0.01% 397
2022
Q1
Sell
-634,685
Closed -$2.71K 715
2021
Q4
$2.71K Buy
+634,685
New +$157M 0.02% 240
2021
Q2
$358K Buy
+2,125
New +$343K 0.16% 135

Other funds holding ALB

Castleview Partners's ALB Position: Q1 2025 in Review

Castleview Partners sold out of Albemarle (ALB) in Q1 2025, closing a stake of 219 shares — an estimated $18.7K sold.

Castleview Partners first reported a position in ALB in Q2 2021 and held it in 10 quarters. The position peaked at $358K in Q2 2021. 764 funds tracked by Wall St. Rank hold ALB as of Q1 2025.

  • Castleview Partners reported no remaining Albemarle position as of Q1 2025 after selling out during the quarter.
  • Castleview Partners sold 219 Albemarle shares in Q1 2025, an estimated $18.7K.
  • Castleview Partners first reported a position in Albemarle in Q2 2021 and held it in 10 quarters.
  • Castleview Partners's Albemarle position peaked at $358K in Q2 2021.
  • 764 funds tracked by Wall St. Rank held Albemarle as of Q1 2025.

Based on Castleview Partners's 13F filing for Q1 2025, filed 22 Apr 2025.